Recherche avancée
Affichage des résultats 3621 à 3640 sur 8880 au total
-
The joint evolutionary histories of <i>Wolbachia</i> and mitochondria in <i>Hypolimnas bolina</i>
S. Charlat, A. Duplouy, E.A. Hornett, E.A. Dyson, N. Davies, G.K Roderick, N. Wedell, G.D.D. Hurst
-
You can`t keep a good parasite down: evolution of a male-killer suppressor uncovers cytoplasmic incompatibility
E.A. Hornett, A.M. Duplouy, N. Davies, G.K. Roderick, N. Wedell, G.D. Hurst, S. Charlat
-
Disrupting the timing of <i>Wolbachia</i>-induced male-killing
S. Charlat, N. Davies, G.K. Roderick, G.D. Hurst
-
Male rarity and putative sex-role reversal in Fijian damselflies (Odonata)
H. van Gossum, C.D. Beatty, S. Charlat, H. Waqa, T. Markwell, J.H. Skevington, M. Tuiwawa, T.N. Sherratt
-
Outbreeding selects for spiteful cytoplasmic elements
J. Engelstädter, S. Charlat
-
Cognitive Therapy versus Rogerian Supportive Therapy in Borderline Personality Disorder
J. Cottraux, I. Druon Note, F. Boutitie, M. Milliery, V. Genouihlac, S.N. Yao, B. Note, E. Mollard, F. Bonasse, Sophie Gaillard, D. Djamoussian, Mey C. De, A. Culem, François Gueyffier
-
New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear
J.-P. Boissel, Michel Cucherat, P. Nonyc, Sylvie Chabaud, François Gueyffier, Jm. Wright, M. Lièvre, A. Leizorovicz
-
Meta-analysis of continuous outcomes combining individual patient data and aggregate data
Rd. Riley, Pc. Lambert, Ja. Staessen, J. Wang, François Gueyffier, L. Thijs, F. Boutitie
-
The JIKEI trial
F. Boutitie, François Gueyffier, Jm. Achard
-
Do We Need to Assess the Effect of Treatment Withdrawal? The Paradigm of Life-Long Prevention
François Gueyffier, T. Bejan-Angoulvant
-
Some reflexions about double blind
R. Boussageon, François Gueyffier, A. Moreau, Y. Gansel, V. Boussageon
-
Does a change in angiotensin-II-formation caused by antihypertensive drugs affect the risk of stroke ? A meta-analysis of trials according to treatment with potentially different effects on angiotensin-II
F. Boutitie, R. Oprisiu, J.M. Achard, H. Mazouz, J. Wang, F.H. Messerli, François Gueyffier, A. Fournier
-
Cardiovascular Risk Stratification in Decision Support Systems: A Probabilistic Approach. Application to pHealth
H. Atoui, J. Fayn, François Gueyffier, P. Rubel
-
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
G. Monneret, A. Lepape, N. Voirin, J. Bohé, F. Venet, A.-L. Debard, H. Thizy, J. Bienvenu, François Gueyffier, Philippe Vanhems
-
The lower the better: Does simplicity lead to absurdity?
François Gueyffier, Jm. Wright
-
Estimation of attributable burden of disease: authors' reply
François Gueyffier, Jm. Wright
-
[Readability of informed consent forms for subjects participating in biomedical research: updating is required]
Adeline Paris, Jean-Luc Cracowski, Nadia Ravanel, Catherine Cornu, François Gueyffier, Béatrice Deygas, Karine Guillot, Jean-Luc Bosson, Marc Hommel
-
Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments
J.-P. Boissel, François Gueyffier, F. Boutitie, S. Pocock, R. Fagard
-
Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome
J.-G. Wang, J.A. Staessen, S. Franklin, R. Fagard, François Gueyffier
-
Pharmacogenetics and responders to a therapy: Theoretical background and practical problems
J.-P. Boissel, François Gueyffier, Michel Cucherat, G. Bricca